A multicenter phase II toxicity study of lung-sparing intensity modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM).

Marjorie G. Zauderer,Andreas Rimner,Kenneth E. Rosenzweig,Abraham J. Wu,Ellen Yorke,Camelia S. Sima,Neha Bhattacharjee,Zarine Patel,Daniel Gomez,Anne S. Tsao,David C Rice,Reza John Mehran,Prasad S. Adusumili,Valerie W. Rusch,Lee M. Krug

A multicenter phase II toxicity study of lung-sparing intensity modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM).

2014

Marjorie G. Zauderer
Andreas Rimner
Kenneth E. Rosenzweig
Abraham J. Wu
Ellen Yorke
Camelia S. Sima
Neha Bhattacharjee
Zarine Patel
Daniel Gomez
Anne S. Tsao
David C Rice
Reza John Mehran
Prasad S. Adusumili
Valerie W. Rusch
Lee M. Krug

7581 Background: Given the trend away from extrapleural pneumonectomy (EPP) towards pleurectomy/decortication (P/D), we are developing a technique to deliver radiation to the pleura in patients wit...

Keywords:

Intensity-modulated radiation therapy
Pathology
Radiology
Mesothelioma
Lung
Toxicity
Medicine
pleural mesothelioma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations